Comparative effectiveness and survival of infliximab, adalimumab, and etanercept for rheumatoid arthritis patients in the Hellenic Registry of Biologics: Low rates of remission and 5-year drug survival
Flouri, Irini, MD, Markatseli, Theodora E., MD, Voulgari, Paraskevi V., MD, Boki, Kyriaki A., MD, Papadopoulos, Ioannis, MD, Settas, Loukas, MD, Zisopoulos, Dimitrios, MD, Skopouli, Fotini N., MD, Iliopoulos, Alexios, MD, Bertsias, George K., MD, Geborek, Pierre, MD, Drosos, Alexandros A., MD, FACR, Boumpas, Dimitrios T., MD, Sidiropoulos, Prodromos, MD
Published in Seminars in arthritis and rheumatism (01.02.2014)
Published in Seminars in arthritis and rheumatism (01.02.2014)
Get full text
Journal Article